ClinicalTrials.govpublic full text
Safety and Efficacy in Patients With Moderate to Severe Subacute and Chronic Atopic Dermatitis
atopic dermatitis, adipose derived mesenchymal stem cell, admsc, ad, inflammatory disease, admc, stem cell, ehlbio, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 836543
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.